Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment

This publication has 33 references indexed in Scilit:

• Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study
  Blood, 2010
• Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international multicenter cohort study
  Journal of Thrombosis and Haemostasis, 2008
• Comparison of low‐molecular‐weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia
  Pediatric Blood & Cancer, 2007
• Central venous line–related thrombosis in children: association with central venous line location and insertion technique
  Blood, 2003
• Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol
  Klinische Padiatrie, 1999
• Right atrial thrombi in children with cancer and indwelling catheters
  The Journal of Pediatrics, 1996
• Hemostasis in Childhood Acute Lymphoblastic Leukemia: Coagulopathy Induced by Disease and Treatment
  Seminars in Thrombosis and Hemostasis, 1995
• Increased Thrombin Generation during Fibrinogen and Platelet Recovery as an Explanation for Hypercoagulability in Children with L-Asparaginase Therapy for ALL or NHL: a Preliminary Report
  Klinische Padiatrie, 1994
• Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 1986
• A syndrome of thrombosis and hemorrhage complicating l-asparaginase therapy for childhood acute lymphoblastic leukemia
  The Journal of Pediatrics, 1982